Arx, LLC
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 21, 2027.
Recent changes
- 2 terms have ended since Aug 23, 2026
- Sep 30 US 8,846,074 Sublingual Films · lapsed on the fee record
- Aug 23 US 11,419,769 Sublingual Films · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,662,297 | Production of unit dose constructs In force · USPTO record | In force | USPTO record | |
| US 9,662,301 | Production of unit dose constructs In force · USPTO record | In force | USPTO record | |
| US 9,814,674 | Production of unit dose constructs In force · USPTO record | In force | USPTO record | |
| US 9,545,376 | Production of unit dose constructs In force · USPTO record | In force | USPTO record | |
| US 11,648,197 | Dispensing Method for Producing Dissolvable Unit Dose Film Constructs In force · High confidence | In force | High confidence | |
| US 12,268,775 | Dispensing method for producing dissolvable unit dose film constructs In force · USPTO record | In force | USPTO record | |
| US 12,691,080 | Fenretinide Formulations, Systems Incorporating Same, and Methods for Their Use In force · High confidence | In force | High confidence |
Also on record, not counted in the 7: 10 patents in force now held by others · 6 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 4 abandoned · 3 no status recorded
Showing 1 to 8 of 8, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/448,754 | Film Formulations Containing Dexmedetomidine and Methods of Producing Them | Aug 11, 2023 | Abandoned |
| 18/448,640 | Film Formulations Containing Dexmedetomidine and Methods of Producing Them | Aug 11, 2023 | Abandoned |
| 18/846,426 | TRANSDERMAL DELIVERY SYSTEMS FOR CERTAIN FACTOR Xa INHIBITORS AND RELATED METHODS FOR THEIR PREPARATION AND USE | Mar 13, 2023 | Pending |
| 18/085,263 | Film Formulations Containing Dexmedetomidine and Methods of Producing Them | Dec 20, 2022 | Abandoned |
| 17/628,021 | Non-Sedating Dexmedetomidine Treatment Regimens | Jul 17, 2020 | Abandoned |
| 15/597,498 | May 17, 2017 | No status recorded | |
| 14/757,886 | Dec 23, 2015 | No status recorded | |
| 12/279,730 | Mar 6, 2007 | No status recorded |